TY - JOUR
T1 - DNA methylation detection
T2 - Recent developments in bisulfite free electrochemical and optical approaches
AU - Bhattacharjee, Ripon
AU - Moriam, Sofia
AU - Umer, Muhammad
AU - Nguyen, Nam-Trung
AU - Shiddiky, Muhammad J.A.
N1 - Funding Information:
This work was supported by the NHMRC CDF (APP1088966) to M. J. A. S. and HDR scholarships to R. B from Griffith University.
Publisher Copyright:
© 2018 The Royal Society of Chemistry.
PY - 2018/10/21
Y1 - 2018/10/21
N2 - DNA methylation is one of the significant epigenetic modifications involved in mammalian development as well as in the initiation and progression of various diseases like cancer. Over the past few decades, an enormous amount of research has been carried out for the quantification of DNA methylation in the mammalian genome. Earlier, most of these methodologies used bisulfite treatment. However, the low conversion, false reading, longer assay time and complex chemical reaction are the common limitations of this method that hinder their application in routine clinical screening. Thus, as an alternative to bisulfite conversion-based DNA methylation detection, numerous bisulfite-free methods have been proposed. In this regard, electrochemical biosensors have gained much attention in recent years for being highly sensitive yet cost-effective, portable, and simple to operate. On the other hand, biosensors with optical readouts enable direct real time detection of biological molecules and are easily adaptable to multiplexing. Incorporation of electrochemical and optical readouts into bisulfite free DNA methylation analysis is paving the way for the translation of this important biomarker into standard patient care. In this review, we provide a critical overview of recent advances in the development of electrochemical and optical readout based bisulfite free DNA methylation assays.
AB - DNA methylation is one of the significant epigenetic modifications involved in mammalian development as well as in the initiation and progression of various diseases like cancer. Over the past few decades, an enormous amount of research has been carried out for the quantification of DNA methylation in the mammalian genome. Earlier, most of these methodologies used bisulfite treatment. However, the low conversion, false reading, longer assay time and complex chemical reaction are the common limitations of this method that hinder their application in routine clinical screening. Thus, as an alternative to bisulfite conversion-based DNA methylation detection, numerous bisulfite-free methods have been proposed. In this regard, electrochemical biosensors have gained much attention in recent years for being highly sensitive yet cost-effective, portable, and simple to operate. On the other hand, biosensors with optical readouts enable direct real time detection of biological molecules and are easily adaptable to multiplexing. Incorporation of electrochemical and optical readouts into bisulfite free DNA methylation analysis is paving the way for the translation of this important biomarker into standard patient care. In this review, we provide a critical overview of recent advances in the development of electrochemical and optical readout based bisulfite free DNA methylation assays.
UR - http://www.scopus.com/inward/record.url?scp=85054431575&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85054431575&partnerID=8YFLogxK
U2 - 10.1039/c8an01348a
DO - 10.1039/c8an01348a
M3 - Review article
C2 - 30226502
AN - SCOPUS:85054431575
SN - 0003-2654
VL - 143
SP - 4802
EP - 4818
JO - Analyst
JF - Analyst
IS - 20
ER -